InvestorsHub Logo

CallMeCrazy

05/18/20 7:00 PM

#297414 RE: GreenBioAnalyst #297408

I agree. My point in posting was to show that combo-therapeutic trials have begun and to look at the process.

I just hope the investing public will not become fed-up with the seemingly daily reports of some drug(s) showing "encouraging" results only to later fail. Remember "The Boy Who Cried Wolf".

Message in reply to:

Remde lacks antiviral to trigger innate..necessary to activate an adaptive immune response. With Baricitinib? That's just mad science,imo. Toxicities issue will kill the combo I doubt the two combined will be any better.